|
Status |
Public on May 25, 2015 |
Title |
VEPH1 expressing SKOV3 cells treated with TGF-ß rep2 |
Sample type |
RNA |
|
|
Source name |
SKOV3 Ovarian cancer cell line
|
Organism |
Homo sapiens |
Characteristics |
treatment: TGF-ß 3 hr treatment transfection: VEPH1
|
Extracted molecule |
total RNA |
Extraction protocol |
Standard Trizol extractions, assessed the RNA using the Agilent Bioanalyzer (all RINS were 10)
|
Label |
biotin
|
Label protocol |
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
|
|
|
Hybridization protocol |
Standard Illumina hybridization protocol
|
Scan protocol |
Standard Illumina scanning protocol
|
Description |
replicate number 2
|
Data processing |
The data were normalised using quantile normalisation with GeneSpring v.12.1
|
|
|
Submission date |
Apr 10, 2015 |
Last update date |
May 25, 2015 |
Contact name |
carl virtanen |
E-mail(s) |
cvirtane@uhnresearch.ca
|
Organization name |
University Health Network
|
Department |
Princess Margaret Genomics Centre
|
Street address |
101 College St
|
City |
Toronto |
State/province |
Ontario |
ZIP/Postal code |
M5G 1L7 |
Country |
Canada |
|
|
Platform ID |
GPL10558 |
Series (1) |
GSE67765 |
VEPH1 expression in ovarian cancer cell lines and its relationship to TGF-B signaling |
|